Literature DB >> 2258002

The first phase insulin response to intravenous glucose is highly reproducible.

G Rayman1, P Clark, A E Schneider, C N Hales.   

Abstract

To determine the reproducibility of the first phase insulin response to intravenous glucose, ten normal subjects underwent two intravenous glucose tolerance tests separated by at least two weeks. Intravenous dextrose (0.3 g/kg) was administered over 2 min by continuous infusion and arterialised-venous samples were taken from a retrogradely cannulated hand vein in the opposite arm. Within subjects, median coefficient of variation for the 3 min insulin was 4.0% (range 1.2-24.3%) and median coefficient of variation for the 0-10 min area was 6.7% (range 1.7-18.8%). These coefficients of variation are close to those of the assay itself (less than 10%). Despite this, between subject responses varied by greater than sixfold. In conclusion, contrary to previous reports the intravenous glucose tolerance test is highly reproducible. This makes it a very valuable tool for further studies of the pathogenesis of diabetes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2258002     DOI: 10.1007/bf00400209

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  9 in total

1.  Inter and intra individual variability of acute insulin response during intravenous glucose tolerance tests.

Authors:  S Bardet; C Pasqual; D Maugendre; J P Remy; B Charbonnel; P Sai
Journal:  Diabete Metab       Date:  1989 Sep-Oct

2.  Duplicates or singletons? An analysis of the need for replication in immunoassay and a computer program to calculate the distribution of outliers, error rate and the precision profile from assay duplicates.

Authors:  P R Raggatt
Journal:  Ann Clin Biochem       Date:  1989-01       Impact factor: 2.057

3.  I. Identification of chemical diabetes. The definition of chemical diabetes.

Authors:  S S Fajans
Journal:  Metabolism       Date:  1973-02       Impact factor: 8.694

4.  Between and within subject variation of the first phase insulin response to intravenous glucose.

Authors:  C P Smith; A C Tarn; J M Thomas; D Overkamp; A Corakci; M O Savage; E A Gale
Journal:  Diabetologia       Date:  1988-02       Impact factor: 10.122

5.  Estimation of arterial PO2, PCO2, pH, and lactate from arterialized venous blood.

Authors:  H V Forster; J A Dempsey; J Thomson; E Vidruk; G A DoPico
Journal:  J Appl Physiol       Date:  1972-01       Impact factor: 3.531

6.  Type I (insulin dependent) diabetes: a disease of slow clinical onset?

Authors:  A C Tarn; C P Smith; K M Spencer; G F Bottazzo; E A Gale
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-07

7.  Pre-type I diabetes. Linear loss of beta cell response to intravenous glucose.

Authors:  S Srikanta; O P Ganda; R E Gleason; R A Jackson; J S Soeldner; G S Eisenbarth
Journal:  Diabetes       Date:  1984-08       Impact factor: 9.461

8.  Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins.

Authors:  W J Sobey; S F Beer; C A Carrington; P M Clark; B H Frank; I P Gray; S D Luzio; D R Owens; A E Schneider; K Siddle
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

9.  Acute and steady-state insulin responses to glucose in nonobese diabetic subjects.

Authors:  R L Lerner; D Porte
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

  9 in total
  7 in total

1.  Deficiency of phosphofructo-1-kinase/muscle subtype in humans impairs insulin secretion and causes insulin resistance.

Authors:  M Ristow; M Vorgerd; M Möhlig; H Schatz; A Pfeiffer
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

2.  Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism.

Authors:  J E Henriksen; F Alford; A Handberg; A Vaag; G M Ward; A Kalfas; H Beck-Nielsen
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

3.  Fetal growth and insulin secretion in adult life.

Authors:  D I Phillips; S Hirst; P M Clark; C N Hales; C Osmond
Journal:  Diabetologia       Date:  1994-06       Impact factor: 10.122

4.  Effects of oral zinc gluconate on glucose effectiveness and insulin sensitivity in humans.

Authors:  J F Brun; R Guintrand-Hugret; C Fons; J Carvajal; C Fedou; M Fussellier; L Bardet; A Orsetti
Journal:  Biol Trace Elem Res       Date:  1995 Jan-Mar       Impact factor: 3.738

5.  First test effect in intravenous glucose tolerance testing.

Authors:  Heba M Ismail; Kama S White; Jeffrey P Krischer; H Peter Chase; David Cuthbertson; Jerry P Palmer
Journal:  Pediatr Diabetes       Date:  2013-08-15       Impact factor: 4.866

6.  [Effect of resection or duct drainage on glucose stimulated beta cell function in chronic pancreatitis].

Authors:  J W Heise; H Becker; C Niederau; H D Röher
Journal:  Langenbecks Arch Chir       Date:  1994

7.  Characterization of glucose-stimulated insulin release protocols in african green monkeys (Chlorocebus aethiops).

Authors:  Shervin Liddie; Haruka Okamoto; Jesper Gromada; Matthew Lawrence
Journal:  J Med Primatol       Date:  2018-10-25       Impact factor: 0.667

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.